Results 201 to 210 of about 9,225,670 (325)

Understanding Mechanisms of Whole Brain and Regional Grey Matter Atrophy in Children With MOGAD

Annals of Clinical and Translational Neurology, Volume 12, Issue 10, Page 1971-1982, October 2025.
ABSTRACT Objective To investigate the mechanisms driving whole brain and regional grey matter (GM) volume changes along with their clinical correlates in paediatric myelin oligodendrocyte glycoprotein antibody (MOG‐Ab)–associated disease (MOGAD). Methods One‐hundred‐nine paediatric MOGAD patients from two UK centres underwent MRI at attack nadir and ...
Ermelinda De Meo, Riccardo Nistri, Michael Eyre, Cheryl Hemingway, Ming Lim, Thomas Rossor, Asthik Biswas, Kshitij Mankad, Ata Siddiqui, Sniya Sudhakar, Declan Chard, Frederik Barkhof, Arman Eshaghi, Olga Ciccarelli, Yael Hacohen   +14 more
wiley   +1 more source

Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study. [PDF]

Ann Clin Transl Neurol
Jiang F, Cai H, Li H, Yin W, Ouyang S, Hu J, Tu E, Fu K, Yin J, Zhao Z, Yang J, Zeng Q, Yang H.   +12 more
europepmc   +1 more source

Pelvic Pain as an Unusual First Presentation of a Demyelinating Disease [PDF]

, 2008
Anthony L. Loschner, John E. Snyder
openalex   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, Volume 12, Issue 10, Page 1983-1991, October 2025.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease - A Case Series. [PDF]

J Ophthalmic Inflamm Infect
Hamdan A, Sharma S, Baynes K, Hajj Ali RA, Lowder CY, Srivastava SK.   +5 more
europepmc   +1 more source

Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease. [PDF]

Int J Mol Sci, 2021
Kim BS.
europepmc   +1 more source

Chapter 4 B Cells and Autoantibodies in the Pathogenesis of Multiple Sclerosis and Related Inflammatory Demyelinating Diseases [PDF]

, 2008
Katherine A. McLaughlin, Kai W. Wucherpfennig   +1 more
openalex   +1 more source

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy

Annals of Clinical and Translational Neurology, Volume 12, Issue 10, Page 2045-2055, October 2025.
ABSTRACT Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Methods In the electronic monitoring of disease activity in patients with CIDP (EMDA‐CIDP) trial, we performed a prospective ...
Lars Masanneck, Jan Voth, Noëmi Gmahl, Konstantin Jendretzky, Niklas Huntemann, Noah M. Werner, Linea Schmidt, Menekse Oeztuerk, Paula Quint, Christina B. Schroeter, Hans Peter Hartung, Thomas Skripuletz, Gerd Meyer zu Hörste, Tobias Ruck, Sven G. Meuth, Marc Pawlitzki   +15 more
wiley   +1 more source

Case report on severe myelin oligodendrocyte glycoprotein antibody-associated disease relapse after ectopic pregnancy and laparoscopic medical abortion: relevance of peripheral inflammation for demyelinating disease activity. [PDF]

Front Immunol
Smertinaite L, Selin K, Vaitiniemi R, Balevicius R, Kollia E, Granberg T, Leite MI, Palace J, Blad H, Karrenbauer VD.   +9 more
europepmc   +1 more source

Combined Central and Peripheral Demyelinating Disease With Good Response to B-Cell Depleting Therapy. [PDF]

Cureus, 2021
Makkawi S, Yonbawi F, Qari Y, Aljinaid M.   +3 more
europepmc   +1 more source